J. Goldman & Co LP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 176 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$6,194,000
+100.5%
307,378
+444.0%
0.26%
+38.2%
Q1 2015$3,089,000
-5.6%
56,500
-44.9%
0.19%
-3.5%
Q3 2014$3,271,000
-52.2%
102,500
-68.9%
0.20%
-60.4%
Q2 2014$6,838,000
-58.2%
330,000
-61.0%
0.50%
-58.5%
Q1 2014$16,360,000
+211.5%
845,500
+290.9%
1.21%
+82.7%
Q4 2013$5,252,000216,3000.66%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 3,921,550$81,254,0004.00%
Palo Alto Investors LP 1,614,536$33,453,0002.49%
Ghost Tree Capital, LLC 100,000$2,072,0001.46%
March Altus Capital Management LP 146,418$3,034,0001.11%
IRONWOOD INVESTMENT MANAGEMENT LLC 296,458$6,143,0000.98%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 999,339$20,706,0000.83%
Visium Asset Management, LP 2,070,870$42,908,0000.67%
AlphaOne Investment Services, LLC 97,448$2,019,0000.54%
CONTINENTAL ADVISORS LLC 57,438$1,190,0000.28%
Tamarack Capital Management, LLC 64,080$1,222,0000.25%
View complete list of AMAG PHARMACEUTICALS INC shareholders